David A. Elliott

9.6k total citations · 1 hit paper
115 papers, 5.6k citations indexed

About

David A. Elliott is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David A. Elliott has authored 115 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 30 papers in Surgery and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David A. Elliott's work include Pluripotent Stem Cells Research (27 papers), Congenital heart defects research (26 papers) and CRISPR and Genetic Engineering (13 papers). David A. Elliott is often cited by papers focused on Pluripotent Stem Cells Research (27 papers), Congenital heart defects research (26 papers) and CRISPR and Genetic Engineering (13 papers). David A. Elliott collaborates with scholars based in Australia, United States and Netherlands. David A. Elliott's co-authors include Andrew G. Elefanty, Christine L. Mummery, Richard P. Harvey, Edouard G. Stanley, Elizabeth Ng, Andrea H. Brand, Timothy J. Kamp, Jianhua Zhang, Gordon Keller and Nicole Dubois and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

David A. Elliott

110 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes

2012 547 citations Christine L. Mummery, David A. Elliott et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Elliott Australia	37	3.9k	1.5k	846	791	709	115	5.6k
Thorsten R. Mempel United States	46	3.6k 0.9×	488 0.3×	904 1.1×	431 0.5×	169 0.2×	81	12.8k
Dimitri Scholz Germany	32	2.7k 0.7×	1.1k 0.7×	336 0.4×	878 1.1×	200 0.3×	77	4.6k
Shannon J. Turley United States	63	5.0k 1.3×	1.4k 0.9×	700 0.8×	319 0.4×	225 0.3×	111	18.6k
Charles Ferguson Australia	45	5.5k 1.4×	736 0.5×	615 0.7×	517 0.7×	299 0.4×	76	7.9k
Takashi Kishimoto Japan	48	3.2k 0.8×	1.0k 0.7×	304 0.4×	222 0.3×	275 0.4×	202	10.4k
Bing Lim United States	58	11.3k 2.9×	1.4k 0.9×	696 0.8×	214 0.3×	394 0.6×	130	15.4k
Junichi Takagi Japan	59	5.8k 1.5×	651 0.4×	595 0.7×	242 0.3×	883 1.2×	202	12.4k
Hongkui Deng China	58	8.5k 2.2×	2.6k 1.7×	1.4k 1.7×	233 0.3×	519 0.7×	170	16.0k
António Bernad Spain	43	5.5k 1.4×	758 0.5×	380 0.4×	360 0.5×	162 0.2×	115	8.2k
Mark A. Behlke United States	53	8.5k 2.2×	419 0.3×	651 0.8×	290 0.4×	230 0.3×	139	11.1k

Countries citing papers authored by David A. Elliott

Since Specialization

Citations

This map shows the geographic impact of David A. Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Elliott more than expected).

Fields of papers citing papers by David A. Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Elliott. The network helps show where David A. Elliott may publish in the future.

Co-authorship network of co-authors of David A. Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Elliott. A scholar is included among the top collaborators of David A. Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Elliott. David A. Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halman, Andreas, et al.. (2025). Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort. Clinical and Translational Science. 18(5). e70246–e70246.

Caverly, Tanner, Matthew J. Schipper, Timothy P. Hofer, et al.. (2025). Prostate Cancer Mortality in Men Aged 70 Years Who Recently Underwent Prostate-Specific Antigen Screening. JAMA Network Open. 8(2). e2459766–e2459766. 1 indexed citations

Williams, Elizabeth, Andreas Halman, David A. Elliott, et al.. (2025). CYP2D6 genotype and associated 5‐HT₃ receptor antagonist outcomes: A systematic review and meta‐analysis. Clinical and Translational Science. 18(2). e70108–e70108.

Ball, Gareth, et al.. (2025). Scoping review of the utilization of wearable devices in pediatric and young adult oncology. npj Digital Medicine. 8(1). 488–488. 3 indexed citations

Blazev, Ronnie, James W. McNamara, Mriga Dutt, et al.. (2024). Affinity Purification-Mass Spectrometry and Single Fiber Physiology/Proteomics Reveals Mechanistic Insights of C18ORF25. Journal of Proteome Research. 23(4). 1285–1297. 5 indexed citations

Elliott, David A., et al.. (2024). Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review. British Journal of Clinical Pharmacology. 90(11). 2724–2741. 1 indexed citations

Herr, Daniel J., David A. Elliott, Jennifer Burns, et al.. (2024). Metastasis-Free Survival after Adjuvant or Salvage Radiation Therapy Following Radical Prostatectomy in a National Healthcare Delivery System. International Journal of Radiation Oncology*Biology*Physics. 120(2). e578–e578.

Conyers, Rachel, Andreas Halman, Tim Spelman, et al.. (2024). Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation. BMJ Open. 14(5). e085115–e085115. 3 indexed citations

Huurne, Menno ter, Benjamin L. Parker, Ning Qing Liu, et al.. (2023). GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals. The American Journal of Human Genetics. 110(9). 1600–1605. 6 indexed citations

10.

Salim, Agus, et al.. (2023). Disparities in spatially variable gene calling highlight the need for benchmarking spatial transcriptomics methods. Genome biology. 24(1). 209–209. 11 indexed citations

11.

Edwards, Donna M., K. Nathan Sankar, Matthew J. Schipper, et al.. (2023). Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 118(4). 963–970. 8 indexed citations

12.

Elliott, David A., et al.. (2021). Optimal Detection of Cardiac Sequelae. JACC CardioOncology. 3(1). 154–156.

13.

Elliott, David A., et al.. (2018). Does a daily consultant ward round affect the outcomes of orthopaedic patients?. British Journal of Hospital Medicine. 79(1). 41–43. 3 indexed citations

14.

Phelan, Dean, David J. Anderson, Sara E. Howden, et al.. (2016). ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy. European Heart Journal. 37(33). 2586–2590. 38 indexed citations

15.

Dambrot, Cheryl, Henk P.J. Buermans, Eszter Varga, et al.. (2014). Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones. Experimental Cell Research. 327(2). 297–306. 15 indexed citations

16.

Soh, Chew-Li, David A. Elliott, Tanya Hatzistavrou, et al.. (2014). FOXN1GFP/w Reporter hESCs Enable Identification of Integrin-β4, HLA-DR, and EpCAM as Markers of Human PSC-Derived FOXN1+ Thymic Epithelial Progenitors. Stem Cell Reports. 2(6). 925–937. 32 indexed citations

17.

Elliott, David A., Michael T. McIntosh, H. Dean Hosgood, et al.. (2008). Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proceedings of the National Academy of Sciences. 105(7). 2463–2468. 136 indexed citations

18.

Elliott, David A. & Richard P. Harvey. (2007). Time to mend a broken heart. Stem Cell Research. 1(1). 4–6. 1 indexed citations

19.

Stennard, Fiona A., Mauro W. Costa, David A. Elliott, et al.. (2003). Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Developmental Biology. 262(2). 206–224. 219 indexed citations

20.

Prall, Owen W.J., David A. Elliott, & Richard Harvey. (2002). Developmental paradigms in heart disease: insights from tinman. Annals of Medicine. 34(3). 148–156. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact